0001209191-21-020248.txt : 20210312
0001209191-21-020248.hdr.sgml : 20210312
20210312173714
ACCESSION NUMBER: 0001209191-21-020248
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klein Lawrence Otto
CENTRAL INDEX KEY: 0001762583
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 21738754
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET 7TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-01-15
2021-01-20
0
0001674416
CRISPR Therapeutics AG
CRSP
0001762583
Klein Lawrence Otto
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
0
1
0
0
CBO & COO
Common Shares
2021-01-15
4
M
0
16334
14.43
A
26942
D
Common Shares
10608
D
This amended Form 4 is being filed to correct the number of shares acquired on January 15, 2021.
The original Form 4 filed on January 20, 2021 inadvertently included the wrong amount of shares beneficially owned after each transaction. This amended Form 4 is being filed to correct the number of shares beneficially owned following the transactions on January 15, 2021.
/s/ Michael Esposito, attorney-in-fact
2021-03-12